1. Grijalva CG, Nuorti JP, Arbogast PG, Martin SW, Edwards KM, Griffin MR. Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis. Lancet. 2007; 369:1179–1186.
Article
2. Sinaniotis CA. Viral pneumoniae in children: incidence and aetiology. Paediatr Respir Rev. 2004; 5:Suppl A. S197–S200.
Article
3. Wolf J, Daley AJ. Microbiological aspects of bacterial lower respiratory tract illness in children: atypical pathogens. Paediatr Respir Rev. 2007; 8:212–219.
Article
4. Montón C, Torres A, El-Ebiary M, Filella X, Xaubet A, de la Bellacasa JP. Cytokine expression in severe pneumonia: a bronchoalveolar lavage study. Crit Care Med. 1999; 27:1745–1753.
Article
5. Antunes G, Evans SA, Lordan JL, Frew AJ. Systemic cytokine levels in community-acquired pneumonia and their association with disease severity. Eur Respir J. 2002; 20:990–995.
Article
6. Puren AJ, Feldman C, Savage N, Becker PJ, Smith C. Patterns of cytokine expression in community-acquired pneumonia. Chest. 1995; 107:1342–1349.
Article
7. Glynn P, Coakley R, Kilgallen I, Murphy N, O'Neill S. Circulating interleukin 6 and interleukin 10 in community acquired pneumonia. Thorax. 1999; 54:51–55.
8. Kellum JA, Kong L, Fink MP, Weissfeld LA, Yealy DM, Pinsky MR, et al. Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study. Arch Intern Med. 2007; 167:1655–1663.
9. Kingsley SM, Bhat BV. Differential Paradigms in Animal Models of Sepsis. Curr Infect Dis Rep. 2016; 18:26.
Article
10. Bennett BL, Garofalo RP, Cron SG, Hosakote YM, Atmar RL, Macias CG, et al. Immunopathogenesis of respiratory syncytial virus bronchiolitis. J Infect Dis. 2007; 195:1532–1540.
Article
11. Hirose Y, Hamada H, Wakui T, Ogawa T, Terai M. Characteristic systemic cytokine responses in children with human bocavirus-positive lower respiratory tract infection. Microbiol Immunol. 2014; 58:215–218.
Article
12. Palomino DC, Marti LC. Chemokines and immunity. Einstein (Sao Paulo). 2015; 13:469–473.
Article
13. Brand HK, Ferwerda G, Preijers F, de Groot R, Neeleman C, Staal FJ, et al. CD4+ T-cell counts and interleukin-8 and CCL-5 plasma concentrations discriminate disease severity in children with RSV infection. Pediatr Res. 2013; 73:187–193.
Article
14. Yu JM, Meng ZY, Dou GF. Recent advances in research on granulocyte colony-stimulating factor--review. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2008; 16:452–456.
Article
15. Kim CK, Callaway Z, Koh YY, Kim SH, Fujisawa T. Airway IFN-γ production during RSV bronchiolitis is associated with eosinophilic inflammation. Lung. 2012; 190:183–188.
Article
16. Petrone L, Cannas A, Aloi F, Nsubuga M, Sserumkuma J, Nazziwa RA, et al. Blood or Urine IP-10 Cannot Discriminate between Active Tuberculosis and Respiratory Diseases Different from Tuberculosis in Children. Biomed Res Int. 2015; 2015:589471.
Article
17. Sumino KC, Walter MJ, Mikols CL, Thompson SA, Gaudreault-Keener M, Arens MQ, et al. Detection of respiratory viruses and the associated chemokine responses in serious acute respiratory illness. Thorax. 2010; 65:639–644.
Article
18. Luo H, Wang D, Che HL, Zhao Y, Jin H. Pathological observations of lung inflammation after administration of IP-10 in influenza virus- and respiratory syncytial virus-infected mice. Exp Ther Med. 2012; 3:76–79.
Article
19. Roe MF, Bloxham DM, Cowburn AS, O'Donnell DR. Changes in helper lymphocyte chemokine receptor expression and elevation of IP-10 during acute respiratory syncytial virus infection in infants. Pediatr Allergy Immunol. 2011; 22:229–234.
Article
20. Fernández-Serrano S, Dorca J, Coromines M, Carratalà J, Gudiol F, Manresa F. Molecular inflammatory responses measured in blood of patients with severe community-acquired pneumonia. Clin Diagn Lab Immunol. 2003; 10:813–820.
Article